Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Probiotics for constipation in adults

Official title: Safety and Efficacy of Probiotics for Constipation Relief in Adults: A Randonmized, Double-blind, Placebo-controlled Trial

Run by Wecare Probiotics Co., Ltd. · NCT07765004 · Data updated 2026-11-12

This randomized, placebo-controlled study tests whether probiotics can help adults with constipation, compared with a placebo over 8 weeks.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment76 (estimated)
SponsorWecare Probiotics Co., Ltd.
Industry-sponsored
Locations1 site (Suzhou, Jiangsu)
StatusRecruiting
StartedAugust 7, 2026
Main results expectedDecember 15, 2026
Study endsDecember 20, 2026
Registry record updatedAugust 17, 2026
Trial IDNCT07765004 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with constipation defined as fewer than 3 spontaneous bowel movements per week and/or Bristol Stool Form Types 1–2.

Probably not a fit

Individuals without a response to probiotics in prior research or with conditions that exclude probiotic efficacy may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial is an randomized, double-blind, placebo-controlled study enrolling adults with constipation. Participants are assigned to receive either a probiotic product or a placebo for 8 weeks. Outcomes include measurements from blood and stool samples as well as multidimensional questionnaires to assess gut function, immune status, and mental well-being. The study aims to determine whether probiotic use can improve gastrointestinal symptoms and related health aspects in this population.

Why it matters

Potential benefit: If successful, participants may experience improved bowel function and related health effects from probiotic use.

How similar studies have gone: Previous probiotic studies in constipation have shown mixed results, making this trial an important test of whether this approach can help this group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 to 65 years (inclusive).
* Diagnosed with constipation, defined as fewer than 3 spontaneous bowel movements per week and/or Bristol Stool Form Scale types 1 or 2.
* Willing and able to comply with the study protocol and complete all required assessments.
* Provide written informed consent prior to any study-related procedures.
* Male and female participants of childbearing potential must agree to use effective contraception voluntarily from 14 days prior to screening until 6 months after the end of the trial. Female participants of non-childbearing potential (e.g., post-menopausal or surgically sterile) are exempt from this requirement.

Exclusion Criteria:

* Use of products with functions similar to the investigational product within a short period prior to screening that may interfere with the evaluation of study outcomes.
* Intention to change dietary habits significantly during the study period.
* Severe allergies or immunodeficiency.
* Women who are pregnant, breastfeeding, or planning to become pregnant during the trial.
* Severe diseases of vital organs (including cardiovascular, pulmonary, hepatic, or renal disease), metabolic diseases (e.g., diabetes, thyroid disorders), malignancy, or severe immune system disorders.
* Use of antibiotics within the past 30 days.
* Severe psychological or psychiatric disorders.
* Poor compliance (e.g., failure to take the test product as instructed or failure to attend scheduled follow-up visits) that would preclude a valid assessment of efficacy.
* Organic constipation (e.g., caused by structural or pathological conditions).
* Irritable bowel syndrome with constipation (IBS-C).
* History of surgical procedures within 30 days prior to screening that may have caused or contributed to constipation symptoms.
* Intake of probiotic or prebiotic supplements within one month prior to the start of the study.
* Any other condition that, in the investigator's opinion, would make the participant unsuitable for participation in the study.

Where it's running

  • Suzhou Ninth People's Hospital
    Suzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.